Welcome to the January 2024 edition of my T4L Education blog. It’s been an exciting several months in the testosterone field, thanks in great part to the series of publications arising from the TRAVERSE trial.
In this short video, I discuss the landmark results of the prostate study from TRAVERSE, which should forever alter clinical practice and medical concepts. I’ve been working on the testosterone and prostate cancer question for 30+ years, and finally there is a large, randomized controlled trial that confirms what the literature has been showing for all those years, contradicting decades of ossified beliefs.
Also, I would be remiss to not mention there is still time to sign up for my CME course, which is sponsored by Harvard Medical School on Testosterone Therapy and Sexual Dysfunction, taking place February 16-17, 2024. I’ve been delighted by the response, as we have already sold out all the seats for the in-person event in Orlando, Florida. However, the course is still available via livestream. Click here to view the program and register.
Abe Morgentaler, MD